MENU

Business Leadership

AP6I0333
 
Arcinova was founded in February 2016 following the acquisition of the Covance Alnwick Research Centre by Ian Shott and Paul Ryan, business partners with a track record of growing established small-and-medium-size enterprises with high growth potential in chemicals, materials, industrial biotechnology, pharmaceuticals and medical technology.
 
Ian is the Executive Chairman & CEO of the highly experienced leadership team, with Paul Ryan as Chief Finance Officer. 
 
This senior team has extensive individual and collective international experience of working in and with biotechnology and large pharmaceutical companies. We have a good balance of site legacy and new multi-business experience of small molecule discovery and development, manufacturing and clinical trial support services.
 

Ian Shott

Executive Chairman and CEO of Arcinova

An Imperial College chemical engineering graduate, Ian has run major global businesses for a number of multi-nationals (ICI, Astra Zeneca, Lonza, Chirex and Rhodia), in the international life science industry for over 20 years. He has been based in the UK, France and Switzerland and has spent considerable periods of time in the USA, Australia and Asia.

He is a fellow of the Royal Academy of Engineering, the Institution of Chemical Engineers and the Royal Society of Chemistry. He chairs Accelerated Innovation for the Chemistry Growth Partnership with Government, is on the Governing Board of Innovate UK and chairs the Enterprise Hub at the RAEng.

Ian has a proven track record of transforming technology-based businesses to deliver exceptional results, by a combination of break-out development, culture change, organic growth, internal re-engineering and external merger, acquisition and divestment.

"I’m an entrepreneur and an engineer. I love working with small businesses with untapped potential. We use our knowledge, experience, tools, judgement and global networks to create value and sustainable growth."

Paul Ryan

Chief Finance Officer

With Ian Shott, Paul has a fifteen-year history running businesses in the global Pharmaceutical Industry from the North East of the UK, with close connections to local universities and involvement in a number of business development and economic regeneration projects in the region.

Paul is a graduate of Newcastle University and KPMG-trained Chartered Accountant.

He has developed his technical, managerial and leadership skills during two decades in senior finance roles in international organisations (public, private and private equity backed) in the food, energy services and pharmaceutical industry.

"I get a real buzz from working with a high growth potential business, where I can use my deep financial experience and extensive tool kit in a disciplined, structured and focused way to help achieve significant results quickly."

Rob Dungworth

Chief Operating Officer

A Chartered Chemist, working in the pharmaceutical industry with companies including Sandoz, Ciba-Geigy, Novartis, Sanofi and GSK. He has a strong background in quality and pharmaceutical production gaining a Post Graduate Diploma in Industrial Pharmaceutical Sciences and subsequently Qualified Person status in 1995.

Rob is an experienced leader with Operations Director roles in both Sanofi and GSK, involving many change management programmes. Ten years practical experience in the application of LEAN practices and the different approaches for the development of a shared organisational LEAN mindset. 

"It is clear to me, that effective and robust business processes are often the backbone to a successful organisation. Moreover, I firmly believe that true success can only be achieved and sustained by the people driving those processes, people steered by sound values including respect for people, passion for performance and customer focus.”

Mark Chadwick

Chief Commercial Officer

Originally a molecular biologist, Mark has spent 18 years in the drug discovery and development industry in both project management and commercial roles.  Previous relevant positions include CEO at AIM-listed Physiomics plc, VP Business Development at Excelsyn and Director of Commercial Operations at BioFocus. 

Mark holds a degree in Genetics from the University of Nottingham, a PhD in Molecular Biology from the University of Newcastle and an MBA from Imperial College London.

"Throughout my career I have always been passionate about providing drug discovery and development services to customers. I gain a great deal of satisfaction from collaborating with biotechnology and pharmaceutical companies and being part of a team who deliver solutions that are often of critical importance to our partners."

Gareth Jenkins

Chief Scientific Officer

Gareth is an experienced senior business executive with a proven track record of leading innovation and technology investments to accelerate the growth of science and technology based businesses. Gareth brings a passion for innovation built on a broad and deep knowledge of chemistry, industrial biotechnology, synthetic biology, continuous manufacturing, process analytical technology and process engineering. 

Gareth holds a degree and PhD in Organic Chemistry from Imperial College, London and an MBA in Entrepreneurship from Manchester Business School and is a Fellow of the Royal Society of Chemistry. He brings over 20 years of industrial experience, covering drug discovery, process development and commercial manufacture.

“Science and technology developments over the last 20 years are poised to make a significant impact on the efficiency and speed of drug substance and product development services. I’m excited about the possibilities for Arcinova to adopt cutting edge approaches which will help our clients to bring their new medicines to market more rapidly and cost-effectively.” 

 

Mike Delroy

Head of Facilities

Mike is an Engineering Manager with 39 years experience in industrial manufacturing plants, having occupied a number of Maintenance Management and Engineering Management roles primarily in electronics and pharmaceutical facilities. Previous pharmaceutical experience being with the global pharmaceutical manufacturer Sanofi, as head of Technical.

Mike has a BSc Degree in Semiconductor Physics and Electronics and holds a Post Grad Diploma in Applied Electronics.

“Empowering individuals, utilizing their experience and knowledge are key drivers in establishing and maintaining  a first class manufacturing facility.”

 

Paul Quigley

Head of Drug Substance

Paul is an organic chemist with a wealth of experience driving small molecule process development and project management. 

Previous relevant employers include Tracerco (Johnson Matthey), Shasun Pharma Solutions, Clariant Life Sciences and Schering-Plough Corp.

Paul was educated at Dublin University where he obtained a degree and a PhD in Organic Chemistry, with an MBA from Warwick Business School.

“I enjoy building, directing and coaching technical teams to drive the commercial application of technology and enhance value for an organisation and achieve excellent results for customers.”

Steve Byard

Head of Molecule Development & Scientific Direction

Steve is an organic chemist  who has spent more than 25 years working in the pharmaceutical industry for major global R&D organisations.  He has particularly strong expertise in physical and molecular characterisation, formulation development, structure elucidation and materials science.

He completed post-graduate studies in the Department of Organic Chemistry at the University of Leeds and is a Chartered Chemist.

Steve is a Fellow of the Royal Society of Chemistry and is currently the secretary for the RSC NMR Discussion Group.

"Collaborating closely with clients of widely differing cultures and with diverse project requirements, from syntheses of drug substances to clinical formulation development, is a privilege. I particularly enjoy projects involving solution or solid-state NMR."

 

Stuart McDougall

Head of Bioanalytical Services

Stuart has 28 years experience in the pharmaceutical industry within Metabolism, Pharmacokinetic and Bioanalysis roles.  Previous relevant positions include global leader of Sanofi-Aventis bioanalytical strategy team and a member of Covance global bioanalytical leadership team.

Stuart is a pharmacology graduate from the University of Dundee, a harmonization team leader for the Global Bioanalytical Consortium (GBC), represents ARCINOVA on the European Bioanalytical Forum (EBF) and is an author and co-author of numerous scientific papers.

“To deliver a great bioanalytical service you need a team of good people who truly understand both the science and the regulations and who you trust to get it right, first time, every time.”